Literature DB >> 8239617

Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi.

K E Aldridge1, C Cammarata, D H Martin.   

Abstract

The in vitro susceptibilities to various antimicrobial agents of 100 strains of beta-lactamase-producing Haemophilus ducreyi recently isolated from patients in New Orleans, La., were determined by an agar dilution method. All strains were highly susceptible to ceftizoxime, ceftriaxone, ceftazidime, azithromycin, erythromycin, ciprofloxacin, and sparfloxacin. beta-Lactam-beta-lactamase inhibitor combinations were less active, but all strains were susceptible to them. Doxycycline exhibited the poorest activity, and the rate of resistance to doxycycline varied depending on the time after inoculation that the MIC was determined.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8239617      PMCID: PMC188105          DOI: 10.1128/AAC.37.9.1986

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

Review 1.  Antimicrobial susceptibility of Haemophilus ducreyi.

Authors:  Y Dangor; R C Ballard; S D Miller; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

Review 2.  Treatment of chancroid, 1989.

Authors:  G P Schmid
Journal:  Rev Infect Dis       Date:  1990 Jul-Aug

Review 3.  Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases.

Authors:  J N Wasserheit
Journal:  Sex Transm Dis       Date:  1992 Mar-Apr       Impact factor: 2.830

4.  Synergistic antibacterial activity of clavulanic acid and amoxicillin against beta-lactamase-producing strains of Haemophilus ducreyi.

Authors:  Y C Girouard; I W Maclean; A R Ronald; W L Albritton
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

5.  Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg.

Authors:  Y R Bilgeri; R C Ballard; M O Duncan; A C Mauff; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

6.  The treatment of chancroid: comparison of one week of sulfisoxazole with single dose doxycycline.

Authors:  G W Hammond; M Slutchuk; C J Lian; J C Wilt; A R Ronald
Journal:  J Antimicrob Chemother       Date:  1979-05       Impact factor: 5.790

7.  In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis.

Authors:  L Slaney; H Chubb; A Ronald; R Brunham
Journal:  J Antimicrob Chemother       Date:  1990-01       Impact factor: 5.790

8.  Plasmid-mediated sulfonamide resistance in Haemophilus ducreyi.

Authors:  W L Albritton; J L Brunton; L Slaney; I MacLean
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

Review 9.  The treatment of chancroid.

Authors:  G P Schmid
Journal:  JAMA       Date:  1986-04-04       Impact factor: 56.272

10.  Single-dose ceftriaxone for chancroid.

Authors:  M I Bowmer; H Nsanze; L J D'Costa; J Dylewski; L Fransen; P Piot; A R Ronald
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

View more
  3 in total

1.  Emergence of Haemophilus ducreyi resistance to trimethoprim-sulfamethoxazole in Rwanda.

Authors:  E Van Dyck; J Bogaerts; H Smet; W M Tello; V Mukantabana; P Piot
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

Review 2.  Chancroid and Haemophilus ducreyi: an update.

Authors:  D L Trees; S A Morse
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

Review 3.  Quinolones in sexually transmitted diseases. Global experience.

Authors:  G L Ridgway
Journal:  Drugs       Date:  1995       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.